No Data
No Data
Trendlines Group Proposes Rights Issue to Raise SG$4.4 Million
Trendlines Group (SGX:42T) proposes a non-brokered rights issue of up to 73.6 million new ordinary shares at SG$0.06 apiece to raise gross proceeds of about SG$4.4 million, according to a Singapore bo
Singapore Shares Recover at Market Close After Mid-Day Fall; IFAST's Shares Jump 5% as Profit Balloons 917% in Q4 2023
Singapore Strait Times Index stocks fell on Thursday mid-day before mounting a recovery by day end to close higher, despite overnight losses in global markets. During the day, the benchmark index rang
Trendlines' Attributable Net Loss Widens in H2 2023; Portfolio Value Decreases
Trendlines Group (SGX:42T) logged an attributable net loss of $38.5 million in the second half of 2023, compared to a net loss of $2.7 million in the year-ago period, according to a Thursday filing. N
Trendlines Co-Chair Steps Down; Interim Co-Chair Named
Trendlines Group's (SGX:42T) co-chair, Todd Dollinger, has stepped down from his role, with Nehama Ronen confirmed as the interim chair from March 8, a company filing said Wednesday. The investment fi
Press Release: Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment
Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment PR Newswire MISGAV, Israel, Feb. 14, 2024 Investors include an undisclosed global strategic inv
Trendlines Flags Wider FY2023 Loss After Cancelling Portfolio Acquisition
Trendlines Group (SGX:42T) expects to post a wider loss for the year ended Dec. 31, 2023, following the cancellation of its previously disclosed non-binding letter of intent to acquire a portfolio com
No Data